SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-290138
Filing Date
2020-11-10
Accepted
2020-11-10 16:06:01
Documents
14
Period of Report
2020-11-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d938912d8k.htm   iXBRL 8-K 30195
2 EX-99.1 d938912dex991.htm EX-99.1 7432
6 GRAPHIC g938912g1110173412649.jpg GRAPHIC 3636
  Complete submission text file 0001193125-20-290138.txt   171655

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20201110.xsd EX-101.SCH 3094
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20201110_lab.xml EX-101.LAB 18856
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20201110_pre.xml EX-101.PRE 11864
7 EXTRACTED XBRL INSTANCE DOCUMENT d938912d8k_htm.xml XML 3455
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 201301123
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences